H.I.G. Capital News
-
January 24, 2023 - Joseph C. Cosgrove Appointed as President and Chief Executive Officer of Leiters
DENVER – January 24, 2023 – Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today that it has appointed Joseph C. Cosgrove as President, Chief Executive Officer, and Director of the Company. Mr. Cosgrove…
-
SAN DIEGO, CALIFORNIA – January 23, 2023 – Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023. Dr. Nova succeeds…
-
November 22, 2022 - BIOVECTRA Named One of Canada’s Top Employers Again in 2023
Charlottetown, P.E.I. – November 22, 2022 – BIOVECTRA was selected as one of Canada’s Top 100 Employers for a second consecutive year and is considered amongst the country’s leading workplaces. BIOVECTRA is a fast growing, forward-thinking contract development, and manufacturing…
-
PALO ALTO, CALIFORNIA – October 4, 2022 – Endpoint Health, Inc., a Precision-FirstTM therapeutics company, today unveiled its newest precision immunology program targeting inflammation mediated by tissue factor (TF)- dependent intracellular signaling. The company will leverage its…
-
September 15, 2022 - Zerigo Health Announces Release of Eczema Solution
SAN DIEGO, CALIFORNIA – September 15, 2022 – Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the launch of a new software release which includes integration of the American Academy…
-
BLOOMFIELD, CONNECTICUT – September 15, 2022 – Evernorth, the health services business of Cigna Corporation ( NYSE: CI), has expanded its Digital Health Formulary to include five new app-based programs to help people better manage their sleep issues, anxiety, alcohol and opioid…
-
SALT LAKE CITY, UTAH – September 8, 2022 – Artemis Health, a best-in-class benefits analytics platform announced a partnership with Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go. This partnership…
-
June 29, 2022 - Leiters Joins the End Drug Shortages Alliance
DENVER – June 29, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages…
-
DENVER – June 9, 2022 – Today Leiters has announced that Memorial Hermann Health System – a non-profit, community-focused, award-winning health system committed to creating healthier Houston communities – has joined the company’s growing list of strategic health system investor…
-
BRIDGEWATER, NJ – April 28, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, and announced today that…
-
April 15, 2022 - Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank
NEW YORK – April 15, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has secured a $15 million term loan from Silicon Valley Bank. Proceeds from the financing were used in part to retire…
-
PARIS & BOSTON – March 8, 2022 – On Target Laboratories, Inc. (‘On Target’) a privately-held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery and Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY)…
-
March 2, 2022 - H.I.G. Capital Expands BioHealth Team with Addition of Gwen Watanabe
STAMFORD – March 2, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated life-science investment affiliate, H.I.G.…
-
DENVER – February 8, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of hospital and ophthalmology compounded sterile preparations announced today that it has completed the purchase of a new manufacturing facility in Buena, New Jersey. The 110,000 square foot…